BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34220814)

  • 1. NLRP3 Regulates IL-4 Expression in TOX
    Huanosta-Murillo E; Alcántara-Hernández M; Hernández-Rico B; Victoria-Acosta G; Miranda-Cruz P; Domínguez-Gómez MA; Jurado-Santacruz F; Patiño-López G; Pérez-Koldenkova V; Palma-Guzmán A; Licona-Limón P; Fuentes-Pananá EM; Lemini-López A; Bonifaz LC
    Front Immunol; 2021; 12():668369. PubMed ID: 34220814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma c-signaling cytokines induce a regulatory T cell phenotype in malignant CD4+ T lymphocytes.
    Kasprzycka M; Zhang Q; Witkiewicz A; Marzec M; Potoczek M; Liu X; Wang HY; Milone M; Basu S; Mauger J; Choi JK; Abrams JT; Hou JS; Rook AH; Vonderheid E; Woetmann A; Odum N; Wasik MA
    J Immunol; 2008 Aug; 181(4):2506-12. PubMed ID: 18684941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell clones from early-stage cutaneous T-cell lymphoma show no polarized Th-1 or Th-2 cytokine profile.
    Harwix S; Zachmann K; Neumann C
    Arch Dermatol Res; 2000 Jan; 292(1):1-8. PubMed ID: 10664008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma.
    Mehdi SJ; Moerman-Herzog A; Wong HK
    BMC Cancer; 2021 May; 21(1):492. PubMed ID: 33941102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of nuclear pro-IL-16 facilitates cell cycle progression in human cutaneous T cell lymphoma.
    Curiel-Lewandrowski C; Yamasaki H; Si CP; Jin X; Zhang Y; Richmond J; Tuzova M; Wilson K; Sullivan B; Jones D; Ryzhenko N; Little F; Kupper TS; Center DM; Cruikshank WW
    J Clin Invest; 2011 Dec; 121(12):4838-49. PubMed ID: 22080865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma.
    Kohnken R; Wen J; Mundy-Bosse B; McConnell K; Keiter A; Grinshpun L; Hartlage A; Yano M; McNeil B; Chakravarti N; William B; Bradner JE; Caligiuri MA; Porcu P; Mishra A
    Blood; 2018 Feb; 131(7):771-781. PubMed ID: 29180399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
    Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular profiling of TOX-deficient neoplastic cells in cutaneous T cell lymphoma.
    Xu J; Huang H; Wang S; Chen Y; Yin X; Zhang X; Zhang Y
    Arch Dermatol Res; 2020 Sep; 312(7):513-525. PubMed ID: 31676945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The receptor NLRP3 is a transcriptional regulator of TH2 differentiation.
    Bruchard M; Rebé C; Derangère V; Togbé D; Ryffel B; Boidot R; Humblin E; Hamman A; Chalmin F; Berger H; Chevriaux A; Limagne E; Apetoh L; Végran F; Ghiringhelli F
    Nat Immunol; 2015 Aug; 16(8):859-70. PubMed ID: 26098997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLRP3 gain-of-function in CD4
    Braga TT; Brandao WN; Azevedo H; Terra FF; Melo ACL; Pereira FV; Andrade-Oliveira V; Hiyane MI; Peron JPS; Camara NOS
    Clin Sci (Lond); 2019 Sep; 133(17):1901-1916. PubMed ID: 31471462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma.
    Clark RA; Shackelton JB; Watanabe R; Calarese A; Yamanaka K; Campbell JJ; Teague JE; Kuo HP; Hijnen D; Kupper TS
    Blood; 2011 Feb; 117(6):1966-76. PubMed ID: 21148332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation.
    Geskin LJ; Viragova S; Stolz DB; Fuschiotti P
    Blood; 2015 Apr; 125(18):2798-805. PubMed ID: 25628470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD164 identifies CD4
    Benoit BM; Jariwala N; O'Connor G; Oetjen LK; Whelan TM; Werth A; Troxel AB; Sicard H; Zhu L; Miller C; Takeshita J; McVicar DW; Kim BS; Rook AH; Wysocka M
    Arch Dermatol Res; 2017 Jan; 309(1):11-19. PubMed ID: 27766406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells.
    Berger CL; Tigelaar R; Cohen J; Mariwalla K; Trinh J; Wang N; Edelson RL
    Blood; 2005 Feb; 105(4):1640-7. PubMed ID: 15514008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma.
    Vowels BR; Lessin SR; Cassin M; Jaworsky C; Benoit B; Wolfe JT; Rook AH
    J Invest Dermatol; 1994 Nov; 103(5):669-73. PubMed ID: 7963654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin-homing CD8+ T lymphocytes show preferential growth in vitro and suppress CD4+ T-cell proliferation in patients with early stages of cutaneous T-cell lymphoma.
    Thestrup-Pedersen K; Parhar R; Wu K; Bertilsson PA; Meyer B; Abu-Amero S; Hainau B; Aleisa A; Alfadley A; Hamadah I; Alajlan A; Al-Hussein K; Al-Mohanna F
    Acta Derm Venereol; 2007; 87(2):118-26. PubMed ID: 17340017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas.
    Urosevic M; Willers J; Mueller B; Kempf W; Burg G; Dummer R
    Blood; 2002 Jan; 99(2):609-17. PubMed ID: 11781245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells.
    Chang TP; Poltoratsky V; Vancurova I
    J Immunol; 2015 Mar; 194(6):2942-53. PubMed ID: 25681335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer cells induce interleukin-22 production from memory CD4
    Voigt C; May P; Gottschlich A; Markota A; Wenk D; Gerlach I; Voigt S; Stathopoulos GT; Arendt KAM; Heise C; Rataj F; Janssen KP; Königshoff M; Winter H; Himsl I; Thasler WE; Schnurr M; Rothenfußer S; Endres S; Kobold S
    Proc Natl Acad Sci U S A; 2017 Dec; 114(49):12994-12999. PubMed ID: 29150554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.